Anselm Jorda
- Co-authors
- Markus ZeitlingerGeorg GelbeneggerFelix BergmannBernd JilmaJolanta M. Siller‐MatulaSusanne Greber‐PlatzerAlexandra KreisslAlexander Zoufaly
- Topics
- SARS-CoV-2 and COVID-19 Research (6 papers)Antibiotics Pharmacokinetics and Efficacy (6 papers)COVID-19 Clinical Research Studies (5 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Anselm Jorda
29 papers receiving 269 citations
Peers
Comparison fields: 5 of 70
- Infectious Diseases 128
- Epidemiology 81
- Pharmacology 50
- Molecular Medicine 29
- Molecular Biology 28
Countries citing papers authored by Anselm Jorda
This map shows the geographic impact of Anselm Jorda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anselm Jorda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anselm Jorda more than expected).
Fields of papers citing papers by Anselm Jorda
This network shows the impact of papers produced by Anselm Jorda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anselm Jorda. The network helps show where Anselm Jorda may publish in the future.
Co-authorship network of co-authors of Anselm Jorda
This figure shows the co-authorship network connecting the top 25 collaborators of Anselm Jorda. A scholar is included among the top collaborators of Anselm Jorda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anselm Jorda. Anselm Jorda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 5 | |
| 7 | 4 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 10 | |
| 12 | 8 | |
| 13 | 9 | |
| 14 | 6 | |
| 15 | 24 | |
| 16 | 0 | |
| 17 | 28 | |
| 18 | 20 | |
| 19 | 2 | |
| 20 | 18 |
About Anselm Jorda
Anselm Jorda is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine and Infectious Diseases, having authored 33 papers that have together received 271 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (23 citations), Infectious Diseases (128 citations) and Molecular Medicine (29 citations). Anselm Jorda has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Markus Zeitlinger, Georg Gelbenegger, Felix Bergmann, Bernd Jilma, Jolanta M. Siller‐Matula, Susanne Greber‐Platzer, Alexandra Kreissl, Alexander Zoufaly, Maria Weber and Manuel Kussmann. Their work appears in journals such as Clinical Infectious Diseases, Critical Care Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.